Broadcasting News

Lee Dong-ha, "Director Kim," Shares Thoughts on Series Finale: "I Was Happy"... Wife So-jin Offers Support: "Good Job"

Lee Dong-ha Shines in the Role of Director Nam in 'Director Kim'

Gim Ga Yeong
2026-07-27 14:40:39
[Edaily Starin Gim Ga Yeong Reporter] After actor Lee Dong-ha shared his thoughts on the finale of the SBS Friday-Saturday drama "Manager Kim," his wife, Girls' Day member Sojin, sent him her support.
On the 26th, Lee Dong-ha posted a photo from the set of “Manager Kim” on his social media with the caption, “Thank you. I was happy.” His wife, Sojin, left a comment on the post saying, “Good job.”
“Manager Kim” is a revenge action drama about an ordinary father fighting to get his only daughter back. In the series, Lee Dong-ha played the role of Director Nam, the chief of staff to the ultimate villain, Joo Kang-chan (played by Joo Sang-wook). Director Nam serves as Joo Kang-chan’s shadow and shield. He prioritizes orders over right and wrong and does not hesitate to get his hands dirty if necessary. Lee Dong-ha is receiving critical acclaim for his outstanding portrayal of Director Nam.
Lee Dong-ha married So-jin, a former member of Girl’s Day, in November 2023.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

"Baek Jong-won Risk" Eases… The BORN Korea Narrows Third-Quarter Loss

As the controversy surrounding Baek Jong-won, CEO of The BORN Korea, begins to subside, the company’s net loss for the third quarter of this year has narrowed significantly. The quarterly operating lo…
2026-11-13 18:23:44

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02